Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High serum levels of reactive nitrogen species and low total antioxidant capacity in patients with resistant hypertension compared to those in age- gender matched healthy controls, controlled hypertension and follow up with propranolol treatment in the extended APPROPRIATE trial.
Ranasinghe HN, Weeratunga PN, Fernando N, Katulanda P, Rajapakse S, Galappatthy P, Handunnetti SM, Constantine GR. Ranasinghe HN, et al. Among authors: handunnetti sm. BMC Res Notes. 2024 Aug 13;17(1):223. doi: 10.1186/s13104-024-06884-8. BMC Res Notes. 2024. PMID: 39138542 Free PMC article.
Serum melatonin and serotonin levels in long-term skilled meditators.
Thambyrajah JC, Dilanthi HW, Handunnetti SM, Dissanayake D. Thambyrajah JC, et al. Among authors: handunnetti sm. Explore (NY). 2023 Sep-Oct;19(5):695-701. doi: 10.1016/j.explore.2023.03.006. Epub 2023 Mar 22. Explore (NY). 2023. PMID: 37061347
Development and Evaluation of In-House ELISAs for the Detection of SARS-CoV-2-Specific Antibodies in COVID-19 Patients in Sri Lanka.
Pathirana SL, Deepachandi B, Gunasekara P, Fernando N, Perera IC, Gangani D, Thambyarajah J, Dasanayake D, de Silva R, Premawansa S, Nitsche A, Handunnetti SM. Pathirana SL, et al. Among authors: handunnetti sm. Int J Microbiol. 2024 Sep 19;2024:1331067. doi: 10.1155/2024/1331067. eCollection 2024. Int J Microbiol. 2024. PMID: 39346702 Free PMC article.
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Handunnetti SM, Anderson MA, Burbury K, Thompson PA, Burke G, Bressel M, Di Iulio J, Hicks RJ, Westerman D, Lade S, Pott C, Agarwal R, Koldej R, Ritchie D, Dreyling M, Dawson MA, Dawson SJ, Seymour JF, Roberts AW, Tam CS. Handunnetti SM, et al. Blood. 2024 Aug 22;144(8):867-872. doi: 10.1182/blood.2023023388. Blood. 2024. PMID: 38662991 Free PMC article. Clinical Trial.
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.
Lew TE, Bennett R, Lin VS, Whitechurch A, Handunnetti SM, Marlton P, Shen Y, Mulligan SP, Casan J, Blombery P, Tam CS, Roberts AW, Seymour JF, Thompson PA, Anderson MA. Lew TE, et al. Among authors: handunnetti sm. Blood Adv. 2024 Mar 26;8(6):1439-1443. doi: 10.1182/bloodadvances.2023011327. Blood Adv. 2024. PMID: 38231032 Free PMC article. No abstract available.
107 results